CRT 2024
Symposium
EVENING SYMPOSIUM – Equity, Inclusion, & Diversity in Interventional Cardiology [Non-CME]
Joaquin E. Cigarroa, MD
Head of the Division of Cardiovascular Medicine
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States
No relationships to disclose
Tracy Wang, MD MHS MSc
Chief of CER
PCORI, North Carolina, United States
No relationships to disclose
Karol Watson, MD, PhD
Attending Cardiologist
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine at UCLA
Redondo Beach, California, United States
No relationships to disclose
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC
Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States
No relationships to disclose
Wayne Batchelor, MD, MHS
Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States
No relationships to disclose
Sara D. Collins, MD
Medical Director
Flourish Research Bowie
Bowie, Maryland, United States
Disclosure information not submitted.
Samuel Conaway, MBA
President Cardiology Sales
Boston Scientific Corporation
No relationships to disclose
Aaron Horne, Jr., MD, MBA
Structural Interventionalist
Summit Health
Berkeley Heights, New Jersey, United States
No relationships to disclose
Gabriel Maluenda, MD
Cath Lab Director
San Borja Hospital/University of Chile
Vitacura, Region Metropolitana, Chile
No relationships to disclose
